Effects of Physical Therapy on the Multisystems of Children With Cerebral Palsy: a Longitudinal Study

December 12, 2022 updated by: Fernanda Cechetti, Federal University of Health Science of Porto Alegre
Cerebral Palsy (CP) refers to childhood movement and posture disorders, whose severity, patterns of motor involvement and associated impairments are very varied. It is the most prevalent type of physical disability in children. Any non-progressive central nervous system (CNS) lesion that occurs in the prenatal, perinatal and postnatal period up to 2 years of life is considered CP. Thus, the present work aims to evaluate, monitor and verify the effects of physical therapy interventions on gross motor function, spasticity, balance, muscle activation, fatigue, respiratory system, functionality and social participation in children with cerebral palsy. This work will use some evaluation scales such as the Gross Motor Function Measure (GMFM-66), the Modified Ashworth Scale (MAS), the Early Clinical Assessment of Balance (ECAB), electromyography, the Fatigue Severity Scale and the Pediatric Functional Status. Scale. In addition to questionnaires, which will be applied directly to parents/caregivers, such as the Young Children's Participation and Environment Measure (YC-PEM), the PEDI (Pediatric Evaluation Disability Inventory) and the Goal Attainment Scaling (GAS).

Study Overview

Study Type

Observational

Enrollment (Anticipated)

33

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • RS
      • Porto Alegre, RS, Brazil
        • Recruiting
        • Franciele Zardo
        • Contact:
          • Franciele

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 8 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Children from 0 to 12 years old, diagnosed with cerebral palsy

Description

Inclusion Criteria:

  • clinical diagnosis of Cerebral Palsy
  • aged between 0-12 years
  • classified in all the levels of the GMFCS
  • those responsible agree to release the minor to participate in the study and sign the Free and Informed Consent Form (FICT)

Exclusion Criteria:

  • have had botulinum toxin applied 6 months before the intervention
  • recent surgery
  • other physical abnormalities, genetic or severe syndromes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Physical Therapy Modalities
Children diagnosed with cerebral palsy will be followed longitudinally in their therapies within the physiotherapeutic treatment.
Handling of the Bobath Concept
Pediasuit
Locomotor training
Active, passive, active-assisted stretching
Psychomotor skills
Virtual reality

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gross Motor Function
Time Frame: 1 year
Measurement of Gross Motor Function
1 year
Gross Motor Function Classification System
Time Frame: Levels I - V. Higher scores mean a worse outcome
Scale Gross Motor Function Classification System
Levels I - V. Higher scores mean a worse outcome

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electromyography
Time Frame: 1 year
Muscle activation
1 year
Early Clinical Assessment of Balance - ECAB
Time Frame: 1 year
Postural control and balance
1 year
Modified Ashworth Scale (MAS)
Time Frame: 1 year
Muscle tone
1 year
Fatigue Severity Scale
Time Frame: 1 year
Muscle fatigue
1 year
Pediatric Functional Status Scale
Time Frame: 1 year
Functional status
1 year
YC-PEM - Young Children's Participation and Environment Measure
Time Frame: 1 year
Level of participation and qualities of the environment in which these activities take place.
1 year
PEDI (Pediatric Evaluation Disability Inventory)
Time Frame: 1 year
Detailed description of the child's functional performance, documenting its longitudinal changes in three functional areas: self-care, mobility and social function.
1 year
GAS (Goal Attainment Scaling)
Time Frame: 1 year
Evaluation of results obtained in family therapy, or in an intervention program
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Franciele Zardo, Msc, UFCSPA: Universidade Federal de Ciencias da Saude de Porto Alegre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2022

Primary Completion (Anticipated)

May 1, 2023

Study Completion (Anticipated)

March 1, 2024

Study Registration Dates

First Submitted

February 5, 2022

First Submitted That Met QC Criteria

November 4, 2022

First Posted (Actual)

November 8, 2022

Study Record Updates

Last Update Posted (Estimate)

December 14, 2022

Last Update Submitted That Met QC Criteria

December 12, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Bobath Concept

Subscribe